Artificial Intelligence (AI) platforms Could Enhance Jaguar Health’s development and anticipated commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
April 14, 2026
Host Jon Najarian interviews CMO, Mick Ruxin, M.D., on the importance of the effectiveness of drugs for specific conditions.